Alan I. Leibowitz

735 total citations
12 papers, 538 citations indexed

About

Alan I. Leibowitz is a scholar working on Immunology, Hepatology and Organic Chemistry. According to data from OpenAlex, Alan I. Leibowitz has authored 12 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Hepatology and 2 papers in Organic Chemistry. Recurrent topics in Alan I. Leibowitz's work include Immune Response and Inflammation (4 papers), Liver Disease and Transplantation (2 papers) and Complement system in diseases (2 papers). Alan I. Leibowitz is often cited by papers focused on Immune Response and Inflammation (4 papers), Liver Disease and Transplantation (2 papers) and Complement system in diseases (2 papers). Alan I. Leibowitz collaborates with scholars based in United States. Alan I. Leibowitz's co-authors include James P. Nolan, Robert Raschke, John C. Peirce, Thomas Wunderlich, James R. Guidry, Robert C. Hartmann, Julius S. Horoszewicz, Mark Wong, William A. Carter and Adrian O. Vladutiu and has published in prestigious journals such as JAMA, Gastroenterology and The American Journal of Medicine.

In The Last Decade

Alan I. Leibowitz

12 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan I. Leibowitz United States	10	164	155	138	99	92	12	538
Sabin S Egger Switzerland	8	44 0.3×	255 1.6×	15 0.1×	62 0.6×	47 0.5×	13	463
Karl Matuszewski United States	15	49 0.3×	96 0.6×	44 0.3×	4 0.0×	198 2.2×	34	809
Walter L. Bender United States	7	27 0.2×	111 0.7×	13 0.1×	11 0.1×	71 0.8×	9	425
William N. Kelly United States	13	156 1.0×	274 1.8×	44 0.3×	3 0.0×	25 0.3×	47	671
Bruce A. Warden United States	16	31 0.2×	83 0.5×	12 0.1×	31 0.3×	417 4.5×	35	1.0k
Mónica Climente Martí Spain	10	89 0.5×	153 1.0×	14 0.1×	5 0.1×	62 0.7×	61	410
Audrey J. Lee United States	12	81 0.5×	157 1.0×	8 0.1×	6 0.1×	84 0.9×	21	496
Sanjay D’Cruz India	15	46 0.3×	88 0.6×	18 0.1×	10 0.1×	203 2.2×	63	650
Dan Henrohn Sweden	10	188 1.1×	515 3.3×	16 0.1×	5 0.1×	18 0.2×	27	774
C. Noblet France	8	44 0.3×	156 1.0×	8 0.1×	5 0.1×	129 1.4×	17	633

Countries citing papers authored by Alan I. Leibowitz

Since Specialization

Citations

This map shows the geographic impact of Alan I. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan I. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan I. Leibowitz more than expected).

Fields of papers citing papers by Alan I. Leibowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan I. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan I. Leibowitz. The network helps show where Alan I. Leibowitz may publish in the future.

Co-authorship network of co-authors of Alan I. Leibowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Alan I. Leibowitz. A scholar is included among the top collaborators of Alan I. Leibowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan I. Leibowitz. Alan I. Leibowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Raschke, Robert, Steven C. Curry, Richard Gerkin, et al.. (2008). Results of a protocol for the management of patients with fulminant liver failure*. Critical Care Medicine. 36(8). 2244–2248. 41 indexed citations

2.

Raschke, Robert, et al.. (1998). A Computer Alert System to Prevent Injury From Adverse Drug Events. JAMA. 280(15). 1317–1317. 291 indexed citations

3.

Khanna, Sandeep, et al.. (1993). Nonfamilial diffuse palmoplantar keratoderma associated with bronchial carcinoma. Journal of the American Academy of Dermatology. 28(2). 295–297. 9 indexed citations

4.

Leibowitz, Alan I. & Robert C. Hartmann. (1981). THE BUDD‐CHIARI SYNDROME IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA—REVISITED. British Journal of Haematology. 49(4). 659–660. 6 indexed citations

5.

Leibowitz, Alan I. & Robert C. Hartmann. (1981). THE BUDD‐CHIARI SYNDROME AND PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA. British Journal of Haematology. 48(1). 1–6. 27 indexed citations

6.

Leibowitz, Alan I.. (1980). The record collector's handbook. 1 indexed citations

7.

Nolan, James P., Alan I. Leibowitz, & A O Vladutiu. (1980). Influence of Carbon Tetrachloride on Circulating Endotoxin after Exogenous Administration of Endotoxin in Rats. Experimental Biology and Medicine. 165(3). 453–456. 10 indexed citations

8.

Leibowitz, Alan I., et al.. (1979). A Prospective Review of Cimetidine use. Drug Intelligence & Clinical Pharmacy. 13(10). 567–571. 12 indexed citations

9.

Carter, William A., Susan S. Leong, Julius S. Horoszewicz, et al.. (1979). Purified human fibroblast interferon in vivo: Skin reactions and effect on bone marrow precursor cells. Cancer Letters. 7(5). 243–249. 9 indexed citations

10.

Carter, William A., et al.. (1979). Fibroblast interferon treatment of a patient with chronic active hepatitis. The American Journal of Medicine. 67(1). 127–131. 20 indexed citations

11.

Nolan, James P. & Alan I. Leibowitz. (1978). Endotoxin and the liver. Gastroenterology. 75(3). 445–449. 26 indexed citations

12.

Nolan, James P. & Alan I. Leibowitz. (1978). Endotoxin and the liver. Gastroenterology. 75(3). 445–449. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact